Kgusler (@kgusler.bsky.social)

FDA's abrupt flip-flop on Moderna's mRNA flu shot highlights growing risks to drug-makers of investing in vaccines The Food and Drug Administration's decision, made public on Feb. 10, 2026, to not review an application to approve Moderna's proposed mRNA-based flu vaccine set off a firestorm of criticism from publi... https://medicalxpress.com/news/2026-02-fda-abrupt-flip-flop-moderna.html